Multibagger penny stock: Kalind board approves fundraising plan, to raise up to ₹500 crore via rights issue LiveMint · Markets 12m ago
Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy CNBC · Economy 28m ago
Applied Materials vs. Marvell Technology: Which Tech Stock Is a Better Buy for 2027? NASDAQ · Markets 33m ago